Method for preventing contrast induced nephropathy

• 1. 一种预防CT造影剂肾病的药物组合物及其制备方法 [P] . 中国专利： CN111317732A . 2020-06-23
• 2. 一种影像科用治疗或预防造影剂肾病的中药及制备方法 [P] . 中国专利： CN104436065A . 2015-03-25
• 3. Method to treat, prevent, or mitigate Contrast induced nephropathy comprising administering a compound inhibitor of neutral Endopeptidase and selected candoxatril dexecadotril, among others, and Biphenyl substituted Compounds, and the use of these compounds to treat, prevent, or m The itigar nephropathy. [P] . CL2013001383A1 . 2013-10-04

  机译： 治疗，预防或减轻对比剂诱发的肾病的方法，包括给予中性内肽酶和选择的坎地沙特韦龙胆三醇等化合物抑制剂和联苯取代的化合物，以及这些化合物在治疗，预防或预防类卡因性肾病中的用途。

• 4. METHOD FOR PREVENTING CONTRAST INDUCED NEPHROPATHY [P] . WO2021141713A1 . 2021-07-15

  机译： 预防造影肾病的方法

• 5. Method for preventing contrast induced nephropathy [P] . US10946178B1 . 2021-03-16

  机译： 预防造影肾病的方法

• 1. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial [J] . Liu Yong, Chen Ji-yan, Huo Yong, The American heart journal . 2016,第Null期
• 2. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial [J] . Liu Yong, Chen Ji-yan, Huo Yong, The American heart journal . 2016,第Null期
• 3. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN (atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy) trial. [J] . Patti G, Ricottini E, Nusca A, The American Journal of Cardiology . 2011,第1期
• 4. The use of statistical analysis methods in assessing long-term prognoses in patients with acute coronary syndrome and contrast-induced nephropathy [C] . N Kobzeva, V Terentev, I Zolotuhina International Scientific-Technical Conference "Dynamics of Technical Systems" . 2020
• 5. Protection by metallothionein from adriamycin induced nephropathy in mice and gene expression profiling during progression of diabetic nephropathy [D] . Yang, Lu 2007
• 6. Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial [O] . Dihia Belabbas, Caroline Koch, Ségolène Chaudru, 2020
• 7. No prophylaxis is non-inferior and cost-saving to prophylactic intravenous hydration in preventing contrast-induced nephropathy on requiring iodinated contrast material administration [O] . Akira Sato, Tomoya Hoshi, Kazutaka Aonuma 2017

• 1. Cordyceps Sinensis prevents contrast-induced nephropathy in diabetic rats by inhibiting p38 MAPK and Akt/mTOR/P70S6K signaling pathways [J] . Kai Zhao1 ,Qiaoying Gao2 . 心血管创新与应用 . 2018,第B01期
• 2. Findings on intraprocedural non-contrast computed tomographic imaging following hepatic artery embolization are associated with development of contrast-induced nephropathy [J] . Mohamed M Soliman ,Debkumar Sarkar ,Ilya Glezerman . 世界肾病学杂志：英文版 . 2020,第2期
• 3. Contrast Agents and Contrast-Induced Nephropathy [J] . Mohammad Hassan Ghadiani ,Pooneh Dehghan . 临床医学国际期刊（英文） . 2015,第7期
• 4. Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography [J] . Yao-Min Hung ,Shoa-Lin Lin ,Shih-Yuan Hung . 世界心脏病学杂志：英文版（电子版） . 2012,第5期
• 5. Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy [J] . Amol Gupta ,Akinsansoye K Dosekun ,Vinod Kumar . 世界心脏病学杂志：英文版（电子版） . 2020,第2期
• 6. 造影剂肾病的预防形同虚设——AMACING研究及PRESERVE研究解读 [C] . 张大东 ,张松 ,张必利 . 第十二届东方心脏病学术会议 . 2018
• 7. 辅酶Q10联合阿托伐他汀对慢性肾功能不全患者冠脉介入术后造影剂肾病的预防作用 [A] . 肖东斌 . 2020